Navigating the Path to Inclusion: Understanding Barriers and Facilitators to Clinical Trial Participation Among Chinese Older Adults in the United States with Multimorbidity
Chinese older adults perceived obstacles to clinical trial participation that could be mitigated by involving trusted physicians in recruitment, using language and culturally concordant materials/staff, and educating patients and community-based physicians. Recognition of differences in attitudes among US- and non-US-born Chinese people may be important to tailoring recruitment strategies.
Authors
- Janice B. Schwartz (ORCID: https://orcid.org/0000-0002-5171-7824)
- Ruey‐Ying Liu (ORCID: https://orcid.org/0000-0002-2770-2147)
- Derjung M. Tarn (ORCID: https://orcid.org/0000-0001-7426-6387)
- Ting Pun
Institutions
- University of California, Los Angeles (US)
- University of California, San Francisco (US)
- Patient-Centered Outcomes Research Institute (US)
- National Chengchi University (TW)
Publication Details
- Journal
- Journal of General Internal Medicine
- Published
- 2024-11-04
- DOI
- https://doi.org/10.1007/s11606-024-09162-2
- Citations
- 2
- Primary Topic
- Ethics in Clinical Research
- Type
- article
- Field-Weighted Citation Impact
- 1.09
Funders
- National Institutes of Health
- University of California, Los Angeles
- University of California, San Francisco
- Center of Excellence in Regulatory Science and Innovation
- Food and Drug Administration
- National Institute on Aging
- National Center for Advancing Translational Sciences
- Clinical and Translational Science Institute, University of California, San Francisco
- David Geffen School of Medicine, University of California, Los Angeles